SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Infinity Pharmaceuticals
An SI Board Since April 2006
Posts SubjectMarks Bans Symbol
210 13 0 INFI
Emcee:  dr.praveen Type:  Moderated
Introduction Market Data Compact
Infinity Pharmaceuticals is an innovative cancer drug discovery and development company that leverages its strength in small molecule drug technologies to bring important new medicines to patients.

Infinity's most advanced drug candidate, IPI-504, is a proprietary, targeted cancer therapy that preferentially induces the death of cancer cells through inhibition of the heat shock protein 90 complex (Hsp90). In preclinical animal studies of a wide variety of hematological malignancies and solid tumors, IPI-504 has demonstrated utility as both a single agent and in combination with other therapies. Infinity owns all rights to IPI-504 and commenced Phase I clinical trials in July 2005.

Infinity's second most advanced drug candidate, IPI-609, is another proprietary small molecule that operates through inhibition of the Hedgehog cell signaling pathway. IPI-609 has demonstrated efficacy as a single agent in preclinical animal models of aggressive pancreatic and prostate cancer. Infinity owns all rights to IPI-609 and expects to file an IND in late 2006.

Drug Pipeline

ipi.com

Genius for Hire (About Julian Adams, President & CSO)

tinyurl.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
210Sorry, following your link from momotif, don't have this thread bookmarked ascaram(o)uche-1/17/2016
209Damn.... for a second there, looked like the microphone would stay open for thosscaram(o)uche-3/4/2013
208Hope that we can get some discussion going. McBio and I have discussed this papescaram(o)uche-3/2/2013
207The PI3K Isoforms p110a and p110d are Essential for Pre-B Cell Receptor Signalinscaram(o)uche-1/11/2013
206$1.3b market cap now, post offering. rkrw-12/14/2012
205Again (see exel thread), I'm sorry that I didn't know about your questioscaram(o)uche-12/14/2012
204Are the folks at Purdue kicking themselves? Cheers, Tucktuck-12/13/2012
203Funny but true, I literally was just about to post but didn't want people tosjemmeri-10/5/2012
202Now $27/share and almost a 750 million MC. For some early stuff and a somewhat tuck-10/5/2012
201Anybody buying the offering (or just adding then) has done pretty well. Up over sjemmeri-9/12/2012
200Rather inevitable I suppose - still 70 million or so is real money; <i>InSteve Lokness-8/9/2012
199New 5 year high - must be more bad news coming.sjemmeri-7/27/2012
198Not sure what significance of todays announcement; <iNEW YORK (AP) -- InfiniSteve Lokness-7/18/2012
197 6:32 AM ET Infinity Pharma Will Issue, Sell 1.89M Cmn Shrs At $14.50/Share Dowsjemmeri-7/18/2012
196The beat goes on - seems it may make the 20s soon regardless. Not piddly volume sjemmeri-7/9/2012
195Too bad the TKI program is just beginning P2. Failure there should send the stotuck-7/6/2012
194<<<<Beats me. Looks like a great long term short.>>>> ISteve Lokness-7/6/2012
193<<<<Beats me. Looks like a great long term short.>>>> TSteve Lokness-6/29/2012
192No, this is amazing. The delta/gamma TKI may be differentiated, in that it seemtuck-6/24/2012
191<<<<Not any more. Infinity today announced that both trials are haltSteve Lokness-6/23/2012
190>>" As the Hedgehog pathway plays distinctly different biological rtuck-6/18/2012
189Apparently Pfizer is in the race to develop FAAH inhibitors, and may have the letuck-5/30/2012
188Busy with other stuff; haven't listened to the CC. Cheers, Tucktuck-1/27/2012
187Arrrrg! Did you listen to the conference call? I too sold some just this week inSteve Lokness-1/27/2012
186IPI-926 whiffs in pancreatic cancer >>Infinity Pharmaceuticals, Inc. (NAtuck-1/27/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News